Introduction
Autism has a worldwide childhood prevalence of approximately one in 160 children (The National Autistic Society, 2017; Autism Spectrum Disorders, 2017) and has become a frequent reason for referral to paediatric genetic services. Because of its clinical and genetic heterogeneity, the underlying cause for autism spectrum disorder (ASD) remains unclear. However, advances in genetic testing have led to the discovery of several highrisk autism candidate genes (SFARI GENE, 2017) .
Here, we focus our attention on one of these high-risk genes, SHANK3. This gene is strongly expressed in the cerebral cortex and cerebellum and encodes a scaffold protein involved in the postsynaptic density of excitatory synapses (Boeckers et al., 2002) .
It is widely known that microdeletions of 22q13 region involving SHANK3 are responsible for the clinically recognisable Phelan-McDermid syndrome (Kolevzon et al., 2014) characterized by global developmental delay, intellectual disability, absent or severely delayed speech, ASD, hypotonia and distinctive facial dysmorphic features. However, SHANK3 variants have also been reported in individuals with autism and/or intellectual disability (Durand et al., 2007; Gauthier et al., 2009 ).
The SHANK3 protein is a crucial component of the postsynaptic density that takes part in the neuroligin-neurexin (NLGN-NRXN) interaction at glutamate synapses. Genetic studies show that the NRXN-NLGN pathway genes contribute susceptibility to ASD, which include cell adhesion molecules NLGN3, NLGN4 (also named NLGN4X ), NRXN1 and scaffolding proteins SHANK2 and SHANK3 (Craig and Kang, 2007) .
Clinical report
The present study was approved by the UK Research Ethics Committee (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). Written informed consent was obtained from the participant. This 10-year-old boy was the fifth pregnancy to healthy nonconsanguineous, White parents. There had been two miscarriages before this pregnancy. He was born at term with a birth weight of 4.5 kg. There was bleeding throughout pregnancy but antenatal scans were normal. There was an increased risk of Down syndrome reported on antenatal screening.
In terms of his development, he could sit unaided at 7 months and walked at 10 months. He had multiple words at 11 months, but subsequently lost speech until the age of 4. At his 2-year check, there were concerns with regard to poor eye contact and limited speech. Following a clinical psychologist assessment, he fulfilled the criteria for severe autism. His parents reported episodes consistent with absence seizures at this stage too.
At age 5, he was attending mainstream school with additional support of two teaching assistants. Communication and social skills were noted to be poor. In terms of behaviour, frustration and violent traits were noted. He was late to develop imaginary play and weakness in social interaction with peers was noted. At age 10, he was attending a special needs school. He was exhibiting pathological demand avoidance and complex social impairments.
Clinical examination did not reveal any dysmorphic features (Fig. 1) .
Investigations so far have included an electroencephalography that was unremarkable. Cytogenetics showing a normal male karyotype (46XY) and fragile X testing was also negative. A microarray revealed no clinically significant imbalances, after which the patient was enroled in the Deciphering Developmental Disorders study that identified a de novo heterozygous c.1231delC, p.Arg411Val frameshift variant in SHANK3.
Discussion
Patients with ASDs and intellectual disability carrying SHANK3 variants have been described in the literature. Several papers have reported SHANK3 variants in ASD patients, consisting of copy number variants (Marshall et al., 2008) , point variants (Moessner et al., 2007; Buxbaum, 2009; Gauthier et al., 2009; Waga et al., 2011) and polymorphisms (Mashayekhi et al., 2016) .
De novo pathogenic variants in SHANK 3 accounted for 1.4 and 0.75% of ASD cohort patients in studies carried out by Durand et al. (2007) and Moessner et al. (2007) , respectively. Bozdagi et al. (2011) reported that the loss of one copy of SHANK3 correlates with behavioural issues reproducing most of the ASD traits, such as deficits in social interaction, social communication and compulsive/repetitive actions. Boccuto et al. (2013) assessed the prevalence of variants in SHANK3 in two cohorts of patients with different subtypes of ASD. Pathogenic alterations in SHANK3 were found in 2.3% of cases (five patients): one 106 kb deletion encompassing the SHANK3 gene, two frameshift variants leading to premature stop codons, one missense variant (p.Pro141Ala), and one splice site variant (c.1820-4G > A). It was also noted that in the cases of the SHANK3 deletion and frameshift variants, the patients showed some degree of speech or developmental delay in association with autistic traits, similar to the patient we report here. It is plausible that the overall level of functional SHANK3 protein is lower as a result of these variants compared with patients with different types of variants. Nemirovsky et al. (2015) reported three siblings with ASD, intellectual disability and absence of language to have germline mosaicism for a heterozygous deletion of a cytosine in the exon 21 of the SHANK3 gene. This resulted in the substitution of five amino acids followed by a premature stop codon (NM_033517:c.3259_3259delC, p.Ser1088Profs*6) (Nemirovsky et al., 2015) . Terrone et al. (2017) went on to describe a family with four members carrying an interstitial microdeletion within SHANK3 leading to intellectual disability. This involved a mother and three children and was the first report of a familial microdeletion. Each carrier in this family presented with symptoms of autism.
However, Liu et al. (2013) did not find any significant association between four high-risk genes (NLGN3, NLGN4, SHANK2 and SHANK3) and ASD cases in a Chinese population. This perhaps highlights the heterogeneous nature of ASD, variability of gene function in Fig. 1 Clinical photography of our patient aged (a) 5 years 9 months and (b) 10 years 3 months. No evidence of dysmorphic features. different populations, but also the role of environmental factors and their potential contribution to the phenotype (Grabrucker, 2013) .
Conclusion
ASDs describe a heterogeneous spectrum of disorders with no single causal gene conferring pathogenicity in the majority of cases. The disease process comprises great genetic and phenotypic complexities.
Our report details a 10-year-old boy with a de novo heterozygous c.1231del, p.Arg411Val frameshift variant in SHANK3, a high-risk candidate autism gene. We report significant speech delay and seizures as an association with this phenotype.
Our case findings appear to be in line with previous findings for SHANK3 and other genes involved in the NRXN-NLGN complex. Further case reports of this nature will continue to expand the phenotype and understand the variable expressivity of SHANK3.
